Published in Am J Epidemiol on February 01, 2002
An integrated approach for risk profiling and spatial prediction of Schistosoma mansoni-hookworm coinfection. Proc Natl Acad Sci U S A (2006) 2.34
Spatial analysis and mapping of malaria risk in Malawi using point-referenced prevalence of infection data. Int J Health Geogr (2006) 2.26
Space-time clustering of childhood malaria at the household level: a dynamic cohort in a Mali village. BMC Public Health (2006) 2.20
A review of spatial methods in epidemiology, 2000-2010. Annu Rev Public Health (2012) 1.95
Space-time variation of malaria incidence in Yunnan province, China. Malar J (2009) 1.89
Comparison of a spatial approach with the multilevel approach for investigating place effects on health: the example of healthcare utilisation in France. J Epidemiol Community Health (2005) 1.79
Spatio-temporal analysis of the role of climate in inter-annual variation of malaria incidence in Zimbabwe. Int J Health Geogr (2006) 1.69
Geographic distribution of human immunodeficiency virus in South Africa. Am J Trop Med Hyg (2007) 1.45
Baseline spatial distribution of malaria prior to an elimination programme in Vanuatu. Malar J (2010) 1.37
Malaria incidence in Limpopo Province, South Africa, 1998-2007. Malar J (2008) 1.35
Spatially-explicit risk profiling of Plasmodium falciparum infections at a small scale: a geostatistical modelling approach. Malar J (2008) 1.33
Spatial parasite ecology and epidemiology: a review of methods and applications. Parasitology (2012) 1.17
Mapping malaria risk in Bangladesh using Bayesian geostatistical models. Am J Trop Med Hyg (2010) 1.13
Serological evidence of discrete spatial clusters of Plasmodium falciparum parasites. PLoS One (2011) 1.08
Characterizing the spatial and temporal variation of malaria incidence in Bangladesh, 2007. Malar J (2012) 1.02
Geographic representation of the jackson heart study cohort to the African-American population in Jackson, Mississippi. Am J Epidemiol (2010) 1.01
Malaria infection has spatial, temporal, and spatiotemporal heterogeneity in unstable malaria transmission areas in northwest Ethiopia. PLoS One (2013) 1.01
Estimation of malaria incidence in northern Namibia in 2009 using Bayesian conditional-autoregressive spatial-temporal models. Spat Spatiotemporal Epidemiol (2013) 0.97
Spatial and temporal patterns of malaria incidence in Mozambique. Malar J (2011) 0.95
Mapping malaria incidence distribution that accounts for environmental factors in Maputo Province--Mozambique. Malar J (2010) 0.94
Spatio-temporal analysis of mortality among children under the age of five in Manhiça (Mozambique) during the period 1997-2005. Int J Health Geogr (2011) 0.90
Generalized seasonal autoregressive integrated moving average models for count data with application to malaria time series with low case numbers. PLoS One (2013) 0.88
A spatial and temporal analysis of notifiable gastrointestinal illness in the Northwest Territories, Canada, 1991-2008. Int J Health Geogr (2012) 0.83
Comparison of infant malaria incidence in districts of Maputo province, Mozambique. Malar J (2011) 0.76
Intercontinental spread of pyrimethamine-resistant malaria. Science (2004) 8.73
Historical review of malarial control in southern African with emphasis on the use of indoor residual house-spraying. Trop Med Int Health (2004) 5.38
A trial of combination antimalarial therapies in children from Papua New Guinea. N Engl J Med (2008) 4.77
Potential effect of climate change on malaria transmission in Africa. Lancet (2003) 4.63
Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing. Nature (2012) 4.37
Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat Genet (2009) 4.30
Antifolate antimalarial resistance in southeast Africa: a population-based analysis. Lancet (2003) 4.26
Proper multivariate conditional autoregressive models for spatial data analysis. Biostatistics (2003) 4.24
Reduction in infection with Plasmodium falciparum one year after the introduction of malaria control interventions on Bioko Island, Equatorial Guinea. Am J Trop Med Hyg (2006) 3.44
Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria. PLoS Med (2009) 3.38
Soil-transmitted helminth infection in South America: a systematic review and geostatistical meta-analysis. Lancet Infect Dis (2013) 3.23
Reported reasons for not using a mosquito net when one is available: a review of the published literature. Malar J (2011) 3.16
Mapping malaria transmission in West and Central Africa. Trop Med Int Health (2006) 3.02
Costs and consequences of large-scale vector control for malaria. Malar J (2008) 2.93
Multiple parasite infections and their relationship to self-reported morbidity in a community of rural Côte d'Ivoire. Int J Epidemiol (2004) 2.84
Association of early interferon-gamma production with immunity to clinical malaria: a longitudinal study among Papua New Guinean children. Clin Infect Dis (2008) 2.80
The risk of malarial infections and disease in Papua New Guinean children. Am J Trop Med Hyg (2007) 2.72
Factors influencing the effectiveness of malaria control in Bioko Island, equatorial Guinea. Am J Trop Med Hyg (2007) 2.59
Developing an evidence-based decision support system for rational insecticide choice in the control of African malaria vectors. J Med Entomol (2006) 2.58
An integrated approach for risk profiling and spatial prediction of Schistosoma mansoni-hookworm coinfection. Proc Natl Acad Sci U S A (2006) 2.34
Relationship between the entomologic inoculation rate and the force of infection for Plasmodium falciparum malaria. Am J Trop Med Hyg (2006) 2.31
Strongyloides stercoralis: Global Distribution and Risk Factors. PLoS Negl Trop Dis (2013) 2.27
Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness. Infect Immun (2009) 2.22
Rapid urban malaria appraisal (RUMA) in sub-Saharan Africa. Malar J (2005) 2.09
Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial. Clin Infect Dis (2010) 2.07
Geographical structure of diversity and differences between symptomatic and asymptomatic infections for Plasmodium falciparum vaccine candidate AMA1. Infect Immun (2003) 2.02
Risk factors and spatial patterns of hookworm infection among schoolchildren in a rural area of western Côte d'Ivoire. Int J Parasitol (2005) 2.01
Molecular evidence for the localization of Plasmodium falciparum immature gametocytes in bone marrow. Blood (2013) 2.01
Evaluation of Plasmodium vivax genotyping markers for molecular monitoring in clinical trials. J Infect Dis (2009) 1.95
Changing patterns of Plasmodium blood-stage infections in the Wosera region of Papua New Guinea monitored by light microscopy and high throughput PCR diagnosis. Am J Trop Med Hyg (2006) 1.93
Differential patterns of infection and disease with P. falciparum and P. vivax in young Papua New Guinean children. PLoS One (2010) 1.87
Parvovirus B19 infection contributes to severe anemia in young children in Papua New Guinea. J Infect Dis (2006) 1.82
Association between naturally acquired antibodies to erythrocyte-binding antigens of Plasmodium falciparum and protection from malaria and high-density parasitemia. Clin Infect Dis (2010) 1.79
Toward an open-access global database for mapping, control, and surveillance of neglected tropical diseases. PLoS Negl Trop Dis (2011) 1.77
Rapid urban malaria appraisal (RUMA) I: epidemiology of urban malaria in Ouagadougou. Malar J (2005) 1.77
Urban farming and malaria risk factors in a medium-sized town in Cote d'Ivoire. Am J Trop Med Hyg (2006) 1.72
Accuracy of urine circulating cathodic antigen (CCA) test for Schistosoma mansoni diagnosis in different settings of Côte d'Ivoire. PLoS Negl Trop Dis (2011) 1.71
Geographical patterns and predictors of malaria risk in Zambia: Bayesian geostatistical modelling of the 2006 Zambia national malaria indicator survey (ZMIS). Malar J (2010) 1.71
Spatio-temporal analysis of the role of climate in inter-annual variation of malaria incidence in Zimbabwe. Int J Health Geogr (2006) 1.69
Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker development. J Immunol (2013) 1.68
Strategies for detection of Plasmodium species gametocytes. PLoS One (2013) 1.67
Comparison of Plasmodium falciparum allelic frequency distribution in different endemic settings by high-resolution genotyping. Malar J (2009) 1.67
Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, tribendimidine, and praziquantel in patients with Opisthorchis viverrini: a randomised, exploratory, open-label, phase 2 trial. Lancet Infect Dis (2010) 1.66
Disparities in parasitic infections, perceived ill health and access to health care among poorer and less poor schoolchildren of rural Côte d'Ivoire. Trop Med Int Health (2005) 1.66
Bayesian spatial risk prediction of Schistosoma mansoni infection in western Côte d'Ivoire using a remotely-sensed digital elevation model. Am J Trop Med Hyg (2007) 1.65
Pharmacokinetics and efficacy of piperaquine and chloroquine in Melanesian children with uncomplicated malaria. Antimicrob Agents Chemother (2007) 1.64
Clinical immunity to malaria. Curr Mol Med (2006) 1.63
Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection. Proc Natl Acad Sci U S A (2008) 1.63
Bayesian geostatistical modeling of Malaria Indicator Survey data in Angola. PLoS One (2010) 1.63
A Bayesian-based approach for spatio-temporal modeling of county level prevalence of Schistosoma japonicum infection in Jiangsu province, China. Int J Parasitol (2004) 1.62
Comparison of diagnostic methods for the detection and quantification of the four sympatric Plasmodium species in field samples from Papua New Guinea. Malar J (2010) 1.60
Models for short term malaria prediction in Sri Lanka. Malar J (2008) 1.60
The use of a GIS-based malaria information system for malaria research and control in South Africa. Health Place (2002) 1.58
Features and prognosis of severe malaria caused by Plasmodium falciparum, Plasmodium vivax and mixed Plasmodium species in Papua New Guinean children. PLoS One (2011) 1.55
The impact of malaria control on perceptions of tourists and tourism operators concerning malaria prevalence in KwaZulu-Natal, 1999/2000 versus 2002/2003. J Travel Med (2007) 1.54
Multiplicity and diversity of Plasmodium vivax infections in a highly endemic region in Papua New Guinea. PLoS Negl Trop Dis (2011) 1.47
Multilocus haplotypes reveal variable levels of diversity and population structure of Plasmodium falciparum in Papua New Guinea, a region of intense perennial transmission. Malar J (2010) 1.47
Geostatistical model-based estimates of Schistosomiasis prevalence among individuals aged ≤ 20 years in West Africa. PLoS Negl Trop Dis (2011) 1.45
Ownership and usage of mosquito nets after four years of large-scale free distribution in Papua New Guinea. Malar J (2012) 1.45
Reduced Plasmodium vivax erythrocyte infection in PNG Duffy-negative heterozygotes. PLoS One (2007) 1.45
Efficacy and side effects of praziquantel against Schistosoma mansoni in a community of western Côte d'Ivoire. Trans R Soc Trop Med Hyg (2004) 1.43
Risk factors for Schistosoma mansoni and hookworm in urban farming communities in western Côte d'Ivoire. Trop Med Int Health (2007) 1.43
Young and vulnerable: spatial-temporal trends and risk factors for infant mortality in rural South Africa (Agincourt), 1992-2007. BMC Public Health (2010) 1.41
Bayesian spatio-temporal modeling of Schistosoma japonicum prevalence data in the absence of a diagnostic 'gold' standard. PLoS Negl Trop Dis (2008) 1.38
Reduced variation around drug-resistant dhfr alleles in African Plasmodium falciparum. Mol Biol Evol (2005) 1.36
Spatially-explicit risk profiling of Plasmodium falciparum infections at a small scale: a geostatistical modelling approach. Malar J (2008) 1.33
Monitoring of larval habitats and mosquito densities in the Sudan savanna of Mali: implications for malaria vector control. Am J Trop Med Hyg (2007) 1.32
Population pharmacokinetics of artemether, lumefantrine, and their respective metabolites in Papua New Guinean children with uncomplicated malaria. Antimicrob Agents Chemother (2011) 1.32
Spatial effects of mosquito bednets on child mortality. BMC Public Health (2008) 1.31
Temporal correlation between malaria and rainfall in Sri Lanka. Malar J (2008) 1.30
Urban agricultural land use and characterization of mosquito larval habitats in a medium-sized town of Côte d'Ivoire. J Vector Ecol (2006) 1.29
Enhanced detection of gametocytes by magnetic deposition microscopy predicts higher potential for Plasmodium falciparum transmission. Malar J (2008) 1.28
Estimating the burden of malaria in Senegal: Bayesian zero-inflated binomial geostatistical modeling of the MIS 2008 data. PLoS One (2012) 1.28
Spatio-temporal malaria transmission patterns in Navrongo demographic surveillance site, northern Ghana. Malar J (2013) 1.27
Evidence that the erythrocyte invasion ligand PfRh2 is a target of protective immunity against Plasmodium falciparum malaria. J Immunol (2010) 1.26
Ecologic covariates of hookworm infection and reinfection in rural Kwazulu-natal/south Africa: a geographic information system-based study. Am J Trop Med Hyg (2005) 1.26
Rapid Urban Malaria Appraisal (RUMA) III: epidemiology of urban malaria in the municipality of Yopougon (Abidjan). Malar J (2006) 1.24
Desbutyl-lumefantrine is a metabolite of lumefantrine with potent in vitro antimalarial activity that may influence artemether-lumefantrine treatment outcome. Antimicrob Agents Chemother (2011) 1.24
Low efficacy of single-dose albendazole and mebendazole against hookworm and effect on concomitant helminth infection in Lao PDR. PLoS Negl Trop Dis (2012) 1.24
Rapid Urban Malaria Appraisal (RUMA) IV: epidemiology of urban malaria in Cotonou (Benin). Malar J (2006) 1.24
How much remains undetected? Probability of molecular detection of human Plasmodia in the field. PLoS One (2011) 1.23
Defining the antigenic diversity of Plasmodium falciparum apical membrane antigen 1 and the requirements for a multi-allele vaccine against malaria. PLoS One (2012) 1.23
Relapses contribute significantly to the risk of Plasmodium vivax infection and disease in Papua New Guinean children 1-5 years of age. J Infect Dis (2012) 1.23
Domestic dog demographic structure and dynamics relevant to rabies control planning in urban areas in Africa: the case of Iringa, Tanzania. BMC Vet Res (2012) 1.23
The use of remotely sensed environmental data in the study of malaria. Geospat Health (2011) 1.22
Clinical and laboratory predictors of imported malaria in an outpatient setting: an aid to medical decision making in returning travelers with fever. Am J Trop Med Hyg (2002) 1.21
Cellular tumor necrosis factor, gamma interferon, and interleukin-6 responses as correlates of immunity and risk of clinical Plasmodium falciparum malaria in children from Papua New Guinea. Infect Immun (2009) 1.20
Intermittent preventive treatment for malaria in Papua New Guinean infants exposed to Plasmodium falciparum and P. vivax: a randomized controlled trial. PLoS Med (2012) 1.20
A growing degree-days based time-series analysis for prediction of Schistosoma japonicum transmission in Jiangsu province, China. Am J Trop Med Hyg (2006) 1.19
Large-scale determinants of intestinal schistosomiasis and intermediate host snail distribution across Africa: does climate matter? Acta Trop (2011) 1.19
Spatially explicit burden estimates of malaria in Tanzania: bayesian geostatistical modeling of the malaria indicator survey data. PLoS One (2012) 1.19
Helminth and intestinal protozoa infections, multiparasitism and risk factors in Champasack province, Lao People's Democratic Republic. PLoS Negl Trop Dis (2011) 1.19
Placental malaria-associated inflammation disturbs the insulin-like growth factor axis of fetal growth regulation. J Infect Dis (2011) 1.18
Modelling the geographical distribution of soil-transmitted helminth infections in Bolivia. Parasit Vectors (2013) 1.18
Evaluation of the antigenic diversity of placenta-binding Plasmodium falciparum variants and the antibody repertoire among pregnant women. Infect Immun (2010) 1.15
Indifferent to disease: a qualitative investigation of the reasons why some Papua New Guineans who own mosquito nets choose not to use them. Soc Sci Med (2012) 1.15
Spatial distribution of, and risk factors for, Opisthorchis viverrini infection in southern Lao PDR. PLoS Negl Trop Dis (2012) 1.15
Mapping malaria risk among children in Côte d'Ivoire using Bayesian geo-statistical models. Malar J (2012) 1.14
Population genetic analysis of Plasmodium falciparum parasites using a customized Illumina GoldenGate genotyping assay. PLoS One (2011) 1.13